Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 331 through 340 of 882 results (Download Results)

Show results per page

Rational design and standardization of serology diagnostics using immunoaffinity-targeted proteomics assays

Drabovich, Andrei P | University of Alberta | Operating Grant | $215,500

CIHR Alberta 2020

COVID-19 Variant Supplement – Engage-COVID-19: A mixed methods study of biomedical, behavioural, and psychosocial aspects of the COVID‑19 pandemic among gay, bisexual, and other men who have sex with men in Canada

Grace, Daniel | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

Kozak, Robert A | University of Toronto | Operating Grant | $44,460

CIHR Ontario 2021

COVID-19 Variant Supplement – Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

James, Michael N | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

Characterization of Cellular and Humoral Immunity Against SARS-CoV-2

Grant, Michael D | Memorial University of Newfoundland | Operating Grant | $497,175

CIHR Newfoundland and Labrador 2020

Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases.

Richard, Stéphane | Lady Davis Institute for Medical Research | Operating Grant | $309,250

CIHR Quebec 2021

Mapping the Emergence and Functional Impact of Novel SARS-CoV-2 Variants

Wrana, Jeffrey L | Sinai Health System | Operating Grant | $446,250

CIHR Ontario 2021

A double blind randomized trial of low-dose naltrexone for post-covid fatigue syndrome

Nacul, Luis | B.C. Women's Hospital | Operating Grant | $742,331

CIHR British Columbia 2021

Long COVID and Episodic Disability: Advancing the Conceptualization, Measurement and Knowledge of Episodic Disability with people living with Long COVID

O'Brien, Kelly K | University of Toronto | Operating Grant | $204,205

CIHR Ontario 2021

COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.

Wilson, Joyce A | University of Saskatchewan | Operating Grant | $50,000

CIHR Saskatchewan 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Rational design and standardization of serology diagnostics using immunoaffinity-targeted proteomics assays

COVID-19 Variant Supplement – Engage-COVID-19: A mixed methods study of biomedical, behavioural, and psychosocial aspects of the COVID‑19 pandemic among gay, bisexual, and other men who have sex with men in Canada

COVID-19 Variant Supplement – Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

COVID-19 Variant Supplement – Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

Characterization of Cellular and Humoral Immunity Against SARS-CoV-2

Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases.

Mapping the Emergence and Functional Impact of Novel SARS-CoV-2 Variants

A double blind randomized trial of low-dose naltrexone for post-covid fatigue syndrome

Long COVID and Episodic Disability: Advancing the Conceptualization, Measurement and Knowledge of Episodic Disability with people living with Long COVID

COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.